Efficacy and safety of ABBV-383, a BCMA bispecific antibody, in black patients with relapsed/refractory multiple myeloma: A subgroup analysis of a phase 1 trial Meeting Abstract
| Authors: | D'Souza, A.; Rodriguez-Valdes, C.; Kumar, S.; Chung, A.; Tuchman, S.; Safah, H.; Weisel, K.; Teipel, R.; Korde, N.; Vij, R.; Bueno, O.; Rosenberg, T.; Pothacamury, R.; Polepally, A.; Ahsan, A.; Lee, S.; Jin, Z.; Spence, S.; Talati, C.; McKay, J.; Voorhees, P. M. |
| Abstract Title: | Efficacy and safety of ABBV-383, a BCMA bispecific antibody, in black patients with relapsed/refractory multiple myeloma: A subgroup analysis of a phase 1 trial |
| Meeting Title: | 21st Annual Meeting and Exposition of the International Myeloma Society |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 24 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sep 25-28 |
| Meeting Location: | Rio de Janeiro, Brazil |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-09-01 |
| Start Page: | S48 |
| Language: | English |
| ACCESSION: | WOS:001325737900077 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(24)01917-7 |
| Notes: | Meeting Abstract: P-014 -- Source: Wos |
